Leading investment bank Piper Sandler has announced the appointment of John Kerins as a managing director on its healthcare investment banking team. In this role, he will serve pharma services clients from the firm’s New York office.
Before joining Piper Sandler, Mr. Kerins spent the past decade as a managing director on Cain Brothers & Company’s healthcare investment team, where he advised clients on mergers and acquisitions (M&A). Previously, he was an investment banker with Deloitte, providing M&A advisory services.
J.P. Peltier, global group head of healthcare investment banking at Piper Sandler, stated, “We are excited to welcome John to the team. His transaction experience combined with strong relationships across the pharma services landscape and with the leading healthcare private equity funds investing in the category are highly complementary to our healthcare investment banking practice. Pharma services is a rapidly growing segment of the market and a key focus for our healthcare investment banking platform. We are confident John’s skillset will enhance our ability to serve our clients and position Piper Sandler for long-term success in this market.”
Mr. Kerins commented, “I am thrilled to be joining Piper Sandler. Their healthcare investment banking team has a trusted reputation of M&A leadership in addition to their deep healthcare services and biopharma research presence. I look forward to working with my new partners to further drive best-in-class client service.”
